Literature DB >> 27226571

Interferon β (IFN-β) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein.

Liyong Zhang1, Wenpei Xiang2, Guoliang Wang1, Zhengzheng Yan1, Zhaowei Zhu1, Zhong Guo1, Rajib Sengupta1, Alex F Chen1, Patricia A Loughran3, Ben Lu4, Qingde Wang1, Timothy R Billiar5.   

Abstract

The sensing of double-stranded RNA (dsRNA) in the liver is important for antiviral defenses but can also contribute to sterile inflammation during liver injury. Hepatocytes are often the target of viral infection and are easily injured by inflammatory insults. Here we sought to establish the pathways involved in the production of type I interferons (IFN-I) in response to extracellular poly(I:C), a dsRNA mimetic, in hepatocytes. This was of interest because hepatocytes are long-lived and, unlike most immune cells that readily die after activation with dsRNA, are not viewed as cells with robust antimicrobial capacity. We found that poly(I:C) leads to rapid up-regulation of inducible nitric oxide synthase (iNOS), double-stranded RNA-dependent protein kinase (PKR), and Src. The production of IFN-β was dependent on iNOS, PKR, and Src and partially dependent on TLR3/Trif. iNOS and Src up-regulation was partially dependent on TLR3/Trif but entirely dependent on PKR. The phosphorylation of TLR3 on tyrosine 759 was shown to increase in parallel to IFN-β production in an iNOS- and Src-dependent manner, and Src was found to directly interact with TLR3 in the endosomal compartment of poly(I:C)-treated cells. Furthermore, we identified a robust NO/cGMP/PKG-dependent feedforward pathway for the amplification of iNOS expression. These data identify iNOS/NO as an integral component of IFN-β production in response to dsRNA in hepatocytes in a pathway that involves the coordinated activities of TLR3/Trif and PKR.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  TIR domain-containing adapter-inducing interferon B (TRIF); Toll-like receptor (TLR); hepatocyte; immunology; inflammation; nitric oxide; nitric oxide synthase

Mesh:

Substances:

Year:  2016        PMID: 27226571      PMCID: PMC4946926          DOI: 10.1074/jbc.M116.717942

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase.

Authors:  M Zamanian-Daryoush; T H Mogensen; J A DiDonato; B R Williams
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  The roles of iNOS in liver ischemia-reperfusion injury.

Authors:  V G Lee; M L Johnson; J Baust; V E Laubach; S C Watkins; T R Billiar
Journal:  Shock       Date:  2001-11       Impact factor: 3.454

Review 3.  Signaling in innate immunity and inflammation.

Authors:  Kim Newton; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

4.  The iNOS/Src/FAK axis is critical in Toll-like receptor-mediated cell motility in macrophages.

Authors:  Ming-Chei Maa; Miao Ying Chang; Jiarung Li; Yu-Yun Li; Ming-Yu Hsieh; Ching-Jau Yang; Yen-Jen Chen; Yahan Li; Hui-Chen Chen; Wei Erh Cheng; Ching-Yun Hsieh; Chun-Wen Cheng; Tzeng-Horng Leu
Journal:  Biochim Biophys Acta       Date:  2010-09-16

Review 5.  Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages.

Authors:  Mayra Solis; Delphine Goubau; Raphaëlle Romieu-Mourez; Pierre Genin; Ahmet Civas; John Hiscott
Journal:  Biochem Pharmacol       Date:  2006-07-17       Impact factor: 5.858

6.  Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .

Authors:  Zhengfan Jiang; Maryam Zamanian-Daryoush; Huiqing Nie; Aristobolo M Silva; Bryan R G Williams; Xiaoxia Li
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

7.  The inducible nitric-oxide synthase (iNOS)/Src axis mediates Toll-like receptor 3 tyrosine 759 phosphorylation and enhances its signal transduction, leading to interferon-β synthesis in macrophages.

Authors:  Ming-Yu Hsieh; Miao Ying Chang; Yen-Jen Chen; Yung Kuo Li; Tsung-Hsien Chuang; Guann-Yi Yu; Chun Hei Antonio Cheung; Hui-Chen Chen; Ming-Chei Maa; Tzeng-Horng Leu
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

8.  Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells.

Authors:  Nan Wang; Yuqiong Liang; Santhana Devaraj; Jie Wang; Stanley M Lemon; Kui Li
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

9.  Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin.

Authors:  A K Nussler; M Di Silvio; T R Billiar; R A Hoffman; D A Geller; R Selby; J Madariaga; R L Simmons
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  ADAR1 Suppresses the Activation of Cytosolic RNA-Sensing Signaling Pathways to Protect the Liver from Ischemia/Reperfusion Injury.

Authors:  Hui Wang; Guoliang Wang; Liyong Zhang; Junbin Zhang; Jinxiang Zhang; Qingde Wang; Timothy R Billiar
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

View more
  8 in total

1.  The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis.

Authors:  Meihong Deng; Yiting Tang; Wenbo Li; Xiangyu Wang; Rui Zhang; Xianying Zhang; Xin Zhao; Jian Liu; Cheng Tang; Zhonghua Liu; Yongzhuo Huang; Huige Peng; Lehui Xiao; Daolin Tang; Melanie J Scott; Qingde Wang; Jing Liu; Xianzhong Xiao; Simon Watkins; Jianhua Li; Huan Yang; Haichao Wang; Fangping Chen; Kevin J Tracey; Timothy R Billiar; Ben Lu
Journal:  Immunity       Date:  2018-10-09       Impact factor: 31.745

2.  Toll-Like Receptor 3 (TLR3) Is Engaged in the Intracellular Survival of the Protozoan Parasite Leishmania (Leishmania) amazonensis.

Authors:  Carolina T Rath; Áislan C Vivarini; José Vitorino Dos Santos; Jorge M Medina; Alessandra M Saliba; Jeremy C Mottram; Ana Paula C A Lima; Teresa Cristina Calegari-Silva; Renata M Pereira; Ulisses G Lopes
Journal:  Infect Immun       Date:  2022-08-22       Impact factor: 3.609

Review 3.  Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses.

Authors:  Yujuan Chen; Junhong Lin; Yao Zhao; Xianping Ma; Huashan Yi
Journal:  J Zhejiang Univ Sci B       Date:  2021-08-15       Impact factor: 3.066

4.  Pure mechanistic analysis of additive neuroprotective effects between baicalin and jasminoidin in ischemic stroke mice.

Authors:  Peng-Qian Wang; Qiong Liu; Wen-Juan Xu; Ya-Nan Yu; Ying-Ying Zhang; Bing Li; Jun Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2018-01-18       Impact factor: 6.150

5.  Type I Interferon Supports Inducible Nitric Oxide Synthase in Murine Hepatoma Cells and Hepatocytes and during Experimental Acetaminophen-Induced Liver Damage.

Authors:  Malte Bachmann; Zoe Waibler; Thomas Pleli; Josef Pfeilschifter; Heiko Mühl
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

Review 6.  Mucosal immunity and tRNA, tRF, and tiRNA.

Authors:  Yueying Chen; Jun Shen
Journal:  J Mol Med (Berl)       Date:  2020-11-16       Impact factor: 4.599

7.  Immunostimulating RNA Delivered by P1500 PEGylated Cationic Liposomes Limits Influenza Infection in C57Bl/6 Mice.

Authors:  Elena P Goncharova; Aleksandra V Sen'kova; Innokenty A Savin; Tat'yana O Kabilova; Marina A Zenkova; Valentin V Vlassov; Elena L Chernolovskaya
Journal:  Pharmaceutics       Date:  2020-09-14       Impact factor: 6.321

8.  Exploiting somatic piRNAs in Bemisia tabaci enables novel gene silencing through RNA feeding.

Authors:  Mosharrof Mondal; Judith K Brown; Alex Flynt
Journal:  Life Sci Alliance       Date:  2020-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.